- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00166192
Treatment of Melasma With Jessner's Solution vs. Trichloroacetic Acid
November 12, 2013 updated by: Zakiya Rice, Emory University
Treatment of Melasma With Jessner's Solution vs. Trichloroacetic Acid: A Comparison of Clinical Efficacy
Melasma is an acquired discoloration of the skin characterized by brown patches.
Chemical peels using agents such as Jessner's solution and trichloroacetic acid (TCA) are commonly used to treat melasma.
A chemical peel involves applying the peeling agent to the skin for a short period.
The skin will peel similar to a sunburn, and moisturizers are applied to the skin.
Although both agents are well-accepted, there have been no good comparisons of the two agents.
The purpose of this study is determine if there is a difference in the effectiveness of these two agents.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
19
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Emory University Dermatology Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults > 18 years old
- Clinical diagnosis of melasma
- Mental capacity to give informed consent
Exclusion Criteria:
- Pregnancy
- H/o allergy to Jessner's solution, tricholoracetetic acid, tretinoin, or hydroquinone
- Active dermatitis
- Presence of cutaneous infection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Chemical Peel
Split face treatment paradigm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical efficacy by clinician's evaluation
Time Frame: 3 months
|
Hyperpigmenation Global Score
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Efficacy by subject's evaluation
Time Frame: 3 months
|
Hyperpigmentation Global Score
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Carl Washington, MD, Emory University Department of Dermatology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2008
Primary Completion (ACTUAL)
January 1, 2010
Study Completion (ACTUAL)
November 1, 2013
Study Registration Dates
First Submitted
September 13, 2005
First Submitted That Met QC Criteria
September 13, 2005
First Posted (ESTIMATE)
September 14, 2005
Study Record Updates
Last Update Posted (ESTIMATE)
November 14, 2013
Last Update Submitted That Met QC Criteria
November 12, 2013
Last Verified
November 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00024850
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Melasma
-
Foundation University IslamabadFauji Foundation HospitalNot yet recruitingMelasma | Melasma (Facial Melasma)Pakistan
-
Gujranwala medical college District Headquarters...CompletedMelasma | Melasma (Facial Melasma)Pakistan
-
Venus Research CenterEnrolling by invitationMelasma | Melasma (Facial Melasma)Egypt
-
Laboratoire Dermatologique ACMCIDP MauritiusRecruitingHealthy | Melasma (Facial Melasma) | Epidermal MelasmaMauritius
-
Pak Emirates Military HospitalCompletedMelasma (Facial Melasma)Pakistan
-
Hina MalikEnrolling by invitationMelasma (Facial Melasma)Pakistan
-
Kasr El Aini HospitalRecruitingMelasma | Facial MelasmaEgypt
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
EgymedicalpediaAswan UniversityRecruiting
-
Mesoestetic Pharma Group S.L.Completed
Clinical Trials on Jessner's solution chemical peel
-
Loyola UniversityCompleted
-
Assiut UniversityUnknown
-
Instituto de Oftalmología Fundación Conde de ValencianaCompleted
-
Massachusetts General HospitalUnknown
-
SUZAN OBAGIWithdrawn
-
Vitality Institute Medical ProductsCompletedWrinkle | Photoaging | Sun Damaged SkinUnited States
-
Raphael Freitas de SouzaFundação de Amparo à Pesquisa do Estado de São PauloCompletedOral Hygiene | Dental Plaque | Oral Candidiasis | Denture StomatitisBrazil
-
Assiut UniversityUnknownAcne Vulgaris | Platelet-Rich Plasma
-
Samsung Medical CenterNot yet recruitingCataract | Dry Eye Disease (DED)South Korea